Tyra Biosciences, Inc. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 3/100
What the filing says
Tyra Biosciences filed a Form 8-K on 2026-09-09 reporting Item 8.01 (Other Events). The filing contains only the standard SEC cover page and XBRL taxonomy extension files. No material transaction, financing, leadership change, clinical result, asset acquisition, or business development is disclosed in the available document text.
Why this rating
No substantive business event disclosed; filing appears to contain only administrative/boilerplate disclosure and XBRL formatting documents.
Extracted items
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.